TMED ETF
T. Rowe Price Health Care ETF
TMED ETF Overview
TMED ETF (T. Rowe Price Health Care ETF) is managed by T.Rowe Price with $33.4M in net assets. TMED expense ratio is 0.44%, holding 115 positions across sectors including Health Care, Information Technology, Financials. Inception date: 2025-06-11.
TMED performance shows a YTD return of 19.31%. The 1-year return is 40.29%. TMED dividend yield stands at 0.46%, paid annually.
TMED top holdings include Eli Lilly & Co. (10.9%), Alnylam Pharmaceuticals Inc. (5.7%), Unitedhealth Group Incorporated (5.4%), Thermo Fisherscientific Inc. (3.8%), Cencora Inc Common Stock Usd.01 (3.3%). Go to all TMED holdings, TMED sectors, or TMED dividends.
TMED can be compared against other funds. Use TMED overlap to find shared positions, or TMED vs another fund for a side-by-side view. TMED alternatives are available via the screener, along with tax-loss harvesting opportunities.